Abstract

Activation of CD$8^+$ cytotoxic T lymphocytes (CTLs) is naturally regarded as a major antitumor mechanism of the immune system. In contrast, CD$4^+$ T cells are commonly classified as helper T cells (HTCs) on the basis of their roles in providing help to the generation and maintenance of effective CD$8^+$ cytotoxic and memory T cells. In order to get a better insight on the role of HTCs in a tumor immune system, we incorporate the third population of HTCs into a previous two dimensional ordinary differential equations (ODEs) model. Further we introduce the adoptive cellular immunotherapy (ACI) as the treatment to boost the immune system to fight against tumors. Compared tumor cells (TCs) and effector cells (ECs), the recruitment of HTCs changes the dynamics of the system substantially, by the effects through particular parameters, i.e., the activation rate of ECs by HTCs, $p$ (scaled as $\rho$), and the HTCs stimulation rate by the presence of identified tumor antigens, $k_2$ (scaled as $\omega_2$). We describe the stability regions of the interior equilibria $E^*$ (no treatment case) and $E^+$ (treatment case) in the scaled $(\rho,\omega_2)$ parameter space respectively. Both $\rho$ and $\omega_2$ can destabilize $E^*$ and $E^+$ and cause Hopf bifurcations. Our results show that HTCs might play a crucial role in the long term periodic oscillation behaviors of tumor immune system interactions. They also show that TCs may be eradicated from the patient's body under the ACI treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call